Does GLOFITAMAB-GXBM Cause Dyspnoea? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Dyspnoea have been filed in association with GLOFITAMAB-GXBM. This represents 1.8% of all adverse event reports for GLOFITAMAB-GXBM.
9
Reports of Dyspnoea with GLOFITAMAB-GXBM
1.8%
of all GLOFITAMAB-GXBM reports
2
Deaths
5
Hospitalizations
How Dangerous Is Dyspnoea From GLOFITAMAB-GXBM?
Of the 9 reports, 2 (22.2%) resulted in death, 5 (55.6%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLOFITAMAB-GXBM. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does GLOFITAMAB-GXBM Cause?
Cytokine release syndrome (107)
Disease progression (68)
Off label use (68)
Death (67)
Pyrexia (45)
No adverse event (28)
Immune effector cell-associated neurotoxicity syndrome (25)
Infection (20)
Pneumonia (14)
Condition aggravated (12)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which GLOFITAMAB-GXBM Alternatives Have Lower Dyspnoea Risk?
GLOFITAMAB-GXBM vs GLUCAGON
GLOFITAMAB-GXBM vs GLUCAGON\GLUCAGON\WATER
GLOFITAMAB-GXBM vs GLUCARPIDASE
GLOFITAMAB-GXBM vs GLUCOPHAGE
GLOFITAMAB-GXBM vs GLUCOSAMINE